Article
Mitigation of NADH: ubiquinone oxidoreductase deficiency by chronic Trolox treatment.
Biochimica et biophysica acta - 1 Jan 2000
Koopman Werner J H, Verkaart Sjoerd, van Emst-de Vries Sjenet E, Grefte Sander, Smeitink Jan A M, Nijtmans Leo G J, Willems Peter H G M
Abstract excerpt
Deficiency of mitochondrial NADH:ubiquinone oxidoreductase (complex I), is associated with a variety of clinical phenotypes such as Leigh syndrome, encephalomyopathy and cardiomyopathy. Circumstantial evidence suggests that increased reactive oxygen species (ROS) levels contribute to the pathogen...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
